Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
J Immunol Methods ; 412: 70-7, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25017507

ABSTRACT

In vitro assessment of the functional responses of leukocytes sometimes requires their isolation from blood, joint and tissues. In this study, we compared the efficiency of two procedures - the gelatin method and Ficoll-Hypaque density centrifugation gradient - to isolate peripheral blood neutrophils of healthy individuals and patients with active rheumatoid arthritis (RA). We also assessed whether these procedures affect the neutrophil activation status. Both purification procedures were concluded in 90min, and yielded cell populations with similar degrees of purity (80-90%), number of neutrophils (1-2×10(6) cells per mL of blood), and viability (97-100%). In vitro neutrophil priming with granulocyte-macrophage colony-stimulating factor (GM-CSF) significantly increased the reactive oxygen species producing ability of the cells stimulated with n-formyl-methionyl-leucyl-phenylalanine (n-fMLP), soluble immune complexes (s-ICs), and insoluble immune complexes (i-ICs). Isolated neutrophils not treated with GM-CSF responded to n-fMLP and i-IC, but not to s-IC. Almost all of the neutrophils (98-100%) purified by both methods expressed FcγRII/CD32 and FcγRIII/CD16, but they did not express significant levels of FcγRI/CD64. Similar results were obtained for healthy individuals' and RA patients' neutrophils. In summary, the gelatin method was comparable to Ficoll-Hypaque gradient in terms of purity, yield, and viability of the neutrophil preparations. Both methods neither primed or activated the neutrophils, nor affected their functional responsiveness. Therefore, both methods are suitable to isolate peripheral blood neutrophils of healthy individuals and RA patients.


Subject(s)
Arthritis, Rheumatoid/diagnosis , Cell Separation/methods , Ficoll/metabolism , Gelatin/metabolism , Neutrophils/metabolism , Receptors, IgG/metabolism , Antigen-Antibody Complex/immunology , Arthritis, Rheumatoid/pathology , Cell Count , Cell Survival , Granulocyte-Macrophage Colony-Stimulating Factor/immunology , Humans , N-Formylmethionine Leucyl-Phenylalanine/immunology , Neutrophil Activation , Neutrophils/pathology , Oxidative Stress , Receptors, IgG/genetics
2.
Biomed Res Int ; 2014: 382891, 2014.
Article in English | MEDLINE | ID: mdl-24822200

ABSTRACT

This work evaluated the physicochemical properties and antioxidant activity of spray dried extracts (SDE) from Psidium guajava L. leaves. Different drying carriers, namely, maltodextrin, colloidal silicon dioxide, Arabic gum, and ß -cyclodextrin at concentrations of 40 and 80% relative to solids content, were added to drying composition. SDE were characterized through determination of the total phenolic, tannins, and flavonoid content. Antioxidant potential of the SDE was assessed by two assays: cellular test that measures the luminol-enhanced chemiluminescence (LumCL) produced by neutrophils stimulated with phorbol myristate acetate (PMA) and the DPPH radical scavenging (DPPH∗ method). In both assays the antioxidant activity of the SDE occurred in a concentration-dependent manner and showed no toxicity to the cells. Using the CLlum method, the IC50 ranged from 5.42 to 6.50 µg/mL. The IC50 of the SDE ranged from 7.96 to 8.11 µg/mL using the DPPH(•) method. Psidium guajava SDE presented significant antioxidant activity; thus they show high potential as an active phytopharmaceutical ingredient. Our findings in human neutrophils are pharmacologically relevant since they indicate that P. guajava SDE is a potential antioxidant and anti-inflammatory agent in human cells.


Subject(s)
Antioxidants/pharmacology , Neutrophils/drug effects , Plant Extracts/chemistry , Plant Leaves/chemistry , Psidium/chemistry , Adolescent , Adult , Antioxidants/chemistry , Biphenyl Compounds/analysis , Biphenyl Compounds/chemistry , Biphenyl Compounds/metabolism , Cell Survival/drug effects , Cells, Cultured , Female , Humans , Luminescent Measurements , Male , Neutrophils/metabolism , Picrates/analysis , Picrates/chemistry , Picrates/metabolism , Plant Extracts/pharmacology , Plant Extracts/toxicity , Young Adult
3.
Parasitology ; 140(2): 210-9, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22975147

ABSTRACT

Toxoplasma gondii stimulates a potent pro-inflammatory response and neutrophils are involved in early infection. Galectin-3 (Gal-3) is an endogenous modulator of inflammatory processes and anti-infective agents, but its interaction with neutrophils in T. gondii infection is still unclear. Here, we evaluated the role of Gal-3 in peritoneal inflammation, reactive oxygen species (ROS) production by neutrophils and survival, after in vivo T. gondii infection with virulent RH strain, using Gal-3 deficient and wild type mice. Animals were inoculated with thioglycollate or tachyzoites, and peritoneal cells were harvested for analysis of the influx of leukocytes. Neutrophils were isolated from peritoneal exudates from infected mice and stimulated with phorbol myristate acetate (PMA) to evaluate ROS production by luminol-dependent chemiluminescence assay. Our results showed that: (1) Gal-3 upregulates peritoneal inflammation, with enhanced recruitment of neutrophils and lymphocytes after thioglycollate stimulation, but does not influence the enhanced neutrophil influx after early T. gondii infection; (2) Gal-3 upregulates ROS generation by inflammatory peritoneal neutrophils from infected mice, but downregulates its production in non-infected mice and (3) Gal-3 does not influence the survival of mice after infection with the virulent T. gondii strain. In conclusion, Gal-3 is essential for ROS generation by neutrophils in the initial acute phase of T. gondii infection and this phenomenon may constitute an attempt to control parasite growth during in vivo infection with the T. gondii virulent strain.


Subject(s)
Galectin 3/metabolism , Neutrophils/immunology , Reactive Oxygen Species/metabolism , Toxoplasmosis, Animal/immunology , Animals , Galectin 3/genetics , Gene Expression Regulation , Mice , Mice, Inbred C57BL , Neutrophil Activation/immunology , Neutrophils/drug effects , Survival Analysis , Thioglycolates/pharmacology , Toxoplasma/drug effects , Toxoplasma/genetics , Toxoplasmosis, Animal/mortality
4.
Braz. j. med. biol. res ; 45(3): 216-221, Mar. 2012. ilus, tab
Article in English | LILACS | ID: lil-618044

ABSTRACT

Evaluating the activity of the complement system under conditions of altered thyroid hormone levels might help elucidate the role of complement in triggering autoimmune processes. Here, we investigated alternative pathway (AP) activity in male Wistar rats (180 ± 10 g) after altering their thyroid hormone levels by treatment with triiodothyronine (T3), propylthiouracil (PTU) or thyroidectomy. T3 and thyroxine (T4) levels were determined by chemiluminescence assays. Hemolytic assays were performed to evaluate the lytic activity of the AP. Factor B activity was evaluated using factor B-deficient serum. An anti-human factor B antibody was used to measure factor B levels in serum by radial immunodiffusion. T3 measurements in thyroidectomized animals or animals treated with PTU demonstrated a significant reduction in hormone levels compared to control. The results showed a reduction in AP lytic activity in rats treated with increasing amounts of T3 (1, 10, or 50 µg). Factor B activity was also decreased in the sera of hyperthyroid rats treated with 1 to 50 µg T3. Additionally, treating rats with 25 µg T3 significantly increased factor B levels in their sera (P < 0.01). In contrast, increased factor B concentration and activity (32 percent) were observed in hypothyroid rats. We conclude that alterations in thyroid hormone levels affect the activity of the AP and factor B, which may in turn affect the roles of AP and factor B in antibody production.


Subject(s)
Animals , Male , Rats , Antithyroid Agents/pharmacology , Complement Factor B/metabolism , Complement Pathway, Alternative/drug effects , Propylthiouracil/pharmacology , Thyroxine/blood , Triiodothyronine/blood , Complement Pathway, Alternative/physiology , Hyperthyroidism/blood , Hyperthyroidism/chemically induced , Hyperthyroidism/immunology , Hypothyroidism/blood , Hypothyroidism/chemically induced , Hypothyroidism/immunology , Luminescent Measurements , Rats, Wistar , Thyroidectomy
5.
Braz J Med Biol Res ; 45(3): 216-21, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22370704

ABSTRACT

Evaluating the activity of the complement system under conditions of altered thyroid hormone levels might help elucidate the role of complement in triggering autoimmune processes. Here, we investigated alternative pathway (AP) activity in male Wistar rats (180 ± 10 g) after altering their thyroid hormone levels by treatment with triiodothyronine (T3), propylthiouracil (PTU) or thyroidectomy. T3 and thyroxine (T4) levels were determined by chemiluminescence assays. Hemolytic assays were performed to evaluate the lytic activity of the AP. Factor B activity was evaluated using factor B-deficient serum. An anti-human factor B antibody was used to measure factor B levels in serum by radial immunodiffusion. T3 measurements in thyroidectomized animals or animals treated with PTU demonstrated a significant reduction in hormone levels compared to control. The results showed a reduction in AP lytic activity in rats treated with increasing amounts of T3 (1, 10, or 50 µg). Factor B activity was also decreased in the sera of hyperthyroid rats treated with 1 to 50 µg T3. Additionally, treating rats with 25 µg T3 significantly increased factor B levels in their sera (P < 0.01). In contrast, increased factor B concentration and activity (32%) were observed in hypothyroid rats. We conclude that alterations in thyroid hormone levels affect the activity of the AP and factor B, which may in turn affect the roles of AP and factor B in antibody production.


Subject(s)
Antithyroid Agents/pharmacology , Complement Factor B/metabolism , Complement Pathway, Alternative/drug effects , Propylthiouracil/pharmacology , Thyroxine/blood , Triiodothyronine/blood , Animals , Complement Pathway, Alternative/physiology , Hyperthyroidism/blood , Hyperthyroidism/chemically induced , Hyperthyroidism/immunology , Hypothyroidism/blood , Hypothyroidism/chemically induced , Hypothyroidism/immunology , Luminescent Measurements , Male , Rats , Rats, Wistar , Thyroidectomy
6.
Fitoterapia ; 81(8): 1102-8, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20637843

ABSTRACT

The reactive oxygen species (ROS) produced by neutrophils are involved in the pathogenesis of several diseases, for which the intake of antioxidants could benefit patients either as a prophylactic or therapeutic treatment. Propolis is among the known antioxidants, and its chemical composition may vary under the influence of seasonality, which may interfere in its biological properties. This work evaluates the role of seasonality on the production of some important compounds of propolis samples produced monthly from November 2001 through October 2002 as well as the effect of these samples on the oxidative metabolism of stimulated neutrophils, by using both luminol and lucigenin to produce chemiluminescence (CLlum and CLluc, respectively). The cytotoxicity of the most active extracts to neutrophils was also investigated. The inhibitory effect of the propolis samples varied significantly during the studied period for both assays (3.4 ± 1.1 to 16.0 ± 1.1 µg/mL for CLlum and 6.2 ± 2.0 to 30.0 ± 5.0 µg/mL for CLluc), which was also observed in the quantitative profile of the main analyzed compounds (aromadendrin-4'-methyl ether, artepillin C, and baccharin). This effect started to become more prominent during the fall and, among all the studied extracts, the one obtained in May displayed the highest inhibitory effect on CL production (3.4 ± 1.1 µg/mL for CLlum and 6.2 ± 2.0 µg/mL for CLluc). The HPLC qualitative profiles of the extracts of propolis samples were quite similar, but there was a huge variation in terms of quantitative profile. It seems that aromadendrin-4'-methyl ether and baccharin play an essential role in the antioxidant activity, while artepillin C is not very important for this effect. The extracts presenting the highest antioxidant activity were produced in May, June, and August, and they did not display cytotoxicity at 25 µg/mL; quercetin, used as control, was not toxic to neutrophils at 8.5 µg/mL.


Subject(s)
Neutrophils/metabolism , Propolis/pharmacology , Animals , Baccharis/chemistry , Baccharis/metabolism , Bees , Brazil , Cells, Cultured , Dose-Response Relationship, Drug , Female , Propolis/chemistry , Rabbits , Seasons , Zymosan
7.
Pharmazie ; 63(1): 67-70, 2008 Jan.
Article in English | MEDLINE | ID: mdl-18271307

ABSTRACT

The tissue damage found in some inflammatory and autoimmune diseases has been shown to be mediated by an increased activation of neutrophil effector functions. In this study, we investigated the inhibitory effect of the phenolic compound butylated hydroxytoluene (BHT) on reactive oxygen species (ROS) generation by opsonized zymosan-stimulated neutrophils, assessed by luminol- and lucigenin-enhanced chemiluminescence (CL-lum and CL-luc, respectively), and some aspects of its mechanism of action. BHT showed concentration-dependent: (a) inhibitory effect on CL-lum and CL-luc; (b) cytotoxic effect, expressed by increased lactate dehydrogenase leakage by the cells; (c) interaction with neutrophil membranes; (d) ROS scavenger activity. These biological effects were observed in the same range of concentrations (0-5 x 10(-5) mol/l). Taken together, the results suggest that inhibition of neutrophil chemiluminescence by BHT was a result of multiple mechanisms, especially a cytotoxic effect probably mediated by BHT interaction with neutrophils membranes, and the ROS scavenging effect.


Subject(s)
Antioxidants/pharmacology , Butylated Hydroxytoluene/pharmacology , Neutrophils/drug effects , Acridines/chemistry , Analysis of Variance , Animals , Cell Membrane/drug effects , Cell Survival/drug effects , Female , In Vitro Techniques , L-Lactate Dehydrogenase/metabolism , Luminescence , Luminol/chemistry , Membrane Fluidity/drug effects , Neutrophils/enzymology , Rabbits , Reactive Oxygen Species/metabolism
8.
Int Immunopharmacol ; 7(7): 989-93, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17499202

ABSTRACT

This study evaluated antibody production against sheep red blood cells (SRBC) in hyperthyroid rats during treatment with triiodothyronine (T(3)). The immune response was evaluated by measuring plaque forming cells (PFC) in the spleen and by enzyme-linked immunosorbent assay (ELISA) in serum of male Wistar rats (180+/-10 g) treated with 25 mug/day of triiodotironine (T(3)) during 7-12 days and immunized with SRBC at the 8th day of treatment. The results showed that anti-SRBC antibody production was significantly decreased in animals treated for 12 days when compared to normal rats immunized with the same antigen, as evaluated by the two assays. These results show that in this experimental model hyperthyroidism decreases antibody response. We previously observed the opposite effect, that is, an increase in this response in hypothyroid rats resulting from the treatment with propylthyouracil, a blocker of thyroid hormone biosynthesis. It is suggested that antibody production is affected by thyroid hormone levels.


Subject(s)
Antibody Formation/immunology , Hyperthyroidism/immunology , Animals , Antibody-Producing Cells/immunology , Antithyroid Agents/pharmacology , Down-Regulation/immunology , Enzyme-Linked Immunosorbent Assay , Erythrocytes/immunology , Hemolytic Plaque Technique , Hyperthyroidism/chemically induced , Immunoglobulin M/biosynthesis , Immunoglobulin M/blood , Injections, Intraperitoneal , Male , Propylthiouracil/pharmacology , Rats , Rats, Wistar/immunology , Sheep, Domestic/blood , Thyrotropin/blood , Triiodothyronine
9.
J Autoimmun ; 25(4): 289-97, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16289666

ABSTRACT

Hypocomplementaemia and low expression of CR1 on erythrocytes (E) of patients with systemic lupus erythematosus (SLE) are associated with defective clearance of circulating immune complexes (IC) and so they may have pathogenic significance. Here, we investigated whether the reduced CR1/E in SLE patients per se might affect the binding of IC to CR1/E. First, we analysed the expression of CR1 on E of active (n=30) and inactive (n=34) SLE patients using a FITC-conjugated mouse anti-CR1 monoclonal antibody E11 and flow cytometry. Both groups of patients had a significantly reduced CR1/E expression compared with healthy controls (n=40). It was also observed that the number of E bearing CR1 was reduced in both groups of SLE patients studied. Second, we determined the functional activity of CR1/E by measuring the binding to E of FITC-bovine serum albumin (BSA)/rabbit anti-BSA complexes, formed at equivalence, which were opsonized with complement from normal human serum (NHS). On the other hand, we did not find differences between the patient and control groups in the ability of E to bind IC/NHS. There was also a positive correlation between the CR1/E expression and the number of E bearing CR1 in control and inactive SLE groups, which was not observed in the group of active SLE patients. Considering the involvement of low levels of complement and CR1/E expression on complex processing, in this in vitro model the results show that an effective coating of the complexes with complement is sufficient to bind them preferentially to CR1 over normal levels of receptor expression.


Subject(s)
Antigen-Antibody Complex/blood , Complement System Proteins/metabolism , Erythrocytes/metabolism , Lupus Erythematosus, Systemic/metabolism , Opsonin Proteins/blood , Receptors, Complement 3b/blood , Receptors, Complement 3b/genetics , Brazil/ethnology , Erythrocytes/immunology , Humans , Lupus Erythematosus, Systemic/ethnology , Lupus Erythematosus, Systemic/immunology , Protein Binding/immunology , Receptors, Complement 3b/antagonists & inhibitors , Receptors, Complement 3b/biosynthesis , Serum/immunology , Serum/metabolism
10.
Cell Biochem Funct ; 23(5): 297-306, 2005.
Article in English | MEDLINE | ID: mdl-15543642

ABSTRACT

Graves' disease shows important systemic inflammatory complications and has been considered to be systemic autoimmune thyroid, skeletal muscle and connective tissue syndrome. Neutrophils participate in the pathophysiology of the two major immune and inflammatory manifestations of the disease, ophthalmopathy and myxedema, and may worsen the inflammatory picture. In this study we analysed some biochemical and functional aspects of neutrophils in Graves' disease patients to assess their participation in these processes. The results show that the complement and/or Fcgamma receptor-mediated oxygen radical production by neutrophils was increased when patient cells were compared with controls. However the percentage of cells expressing complement and IgG receptors and the per-cell fluorescence, were similar, indicating that the increased oxidative burst was not due to an abnormal expression of mediating receptors. The production of hydrogen peroxide was also increased in hyperthyroid patient neutrophils as compared to controls. Conversely, antioxidant defences (superoxide dismutase activity and reduced glutathione content) in neutrophils from patients were not significantly different from healthy controls. The liberation of potent oxidative compounds together with the absence of adequate quenching of them by antioxidant mechanisms could be responsible for greater tissue damage in inflammatory conditions, as is the case in ophthalmopathy and myxedema patients. Considering our results and those of other workers, we encourage and suggest an associated antioxidant therapy to complement the conventional anti-thyroid therapy, especially in obvious inflammatory cases and in individuals who smoke.


Subject(s)
Graves Disease/immunology , Neutrophils/immunology , Neutrophils/metabolism , Antigen-Antibody Complex/pharmacology , Brazil , Case-Control Studies , Complement System Proteins/metabolism , Glutathione/metabolism , Humans , Hydrogen Peroxide/metabolism , Luminescent Measurements , Luminol/pharmacology , Neutrophils/drug effects , Receptors, IgG/metabolism , Respiratory Burst/drug effects , Superoxide Dismutase/metabolism , Superoxides/metabolism
11.
J Ethnopharmacol ; 94(1): 59-65, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15261964

ABSTRACT

The activity of a crude ethanol extract of green propolis and its fractions obtained by partition with hexane, chloroform and n-butanol was assessed on luminol- and lucigenin- enhanced chemiluminescence (CL) produced by rabbit neutrophils (PMNs) stimulated with particles of serum-opsonized zymosan (OZ). The total production of reactive oxygen species (ROS) by PMNs was measured by the luminol-enhanced CL (LumCL) assay and the production of the superoxide anion (O2*-) by the lucigenin-enhanced CL (LucCL) assay. All evaluated propolis samples had inhibitory effect on the LumCL and LucCL, which was concentration dependent. The n-butanol and chloroform fractions displayed the highest inhibitory effect on the LumCL produced by PMNs stimulated with OZ, in comparison with both the ethanol extract and the hexane fraction. Besides, the hexane fraction was the one which presented the highest effect for the LucCL assay. Some isolated compounds from both n-butanol and chloroform fractions were also assessed, including kaempferide, isosakuranetin, aromadendrine-4'-methyl-ether and 3-prenyl-p-coumaric acid. Kaempferide presented the highest inhibitory effect on the LumCL in comparison with the other compounds. Moreover, under the conditions assessed, the studied green propolis samples and isolated compounds were not toxic to the rabbit PMNs.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Neutrophils/drug effects , Propolis/pharmacology , Reactive Oxygen Species/antagonists & inhibitors , Superoxides/antagonists & inhibitors , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/toxicity , Brazil , Chromatography, High Pressure Liquid , Dose-Response Relationship, Drug , Female , In Vitro Techniques , Luminescent Measurements , Neutrophils/metabolism , Propolis/chemistry , Propolis/toxicity , Rabbits , Zymosan
12.
Immunol Invest ; 33(1): 39-50, 2004 Feb.
Article in English | MEDLINE | ID: mdl-15015831

ABSTRACT

When neutrophil phagocytes are stimulated by IgG containing immune complexes (IgG-IC), with or without the participation of the complement system, they show a sharp increase in oxygen uptake and begin to release large quantities of superoxide anions (O2-) and hydrogen peroxide (H2O2) into the surrounding medium. The aim of the present investigation was to provide insights into the production and release of O2- by rabbit neutrophils activated with immune complexes (IC) containing IgG antibodies of different functional affinity, opsonized and not opsonized by complement system components. For this purpose, two populations of polyclonal anti-ovalbumin (OVA) IgG antibodies with different functional affinity, 5 x 10(8) M(-1) and 2 x 10(7) M(-1), were prepared. The production of O2- was measured spectrophotometrically by a method using the superoxide dismutase-inhibited reduction of ferricytochrome C to the ferrous form. The activation of complement by different IgG-IC was determined by estimating the total residual haemolytic activity of the alternative and classical pathways in sera treated with different concentrations of anti-OVA IgG/ OVA immune complexes formed at equivalence. The results showed that: 1) antibody functional affinity influenced O2- production and the complement-fixing activity induced by the IC. In general, the higher functional affinity antibodies were more efficient in stimulating the respiratory burst of neutrophils and in activating complement by the classical and alternative pathways than the lower functional affinity antibodies at all IC concentrations tested; 2) complement components incorporated into the immune complex lattice caused an increase in the stimulatory activity of both IgG antibodies to produce O2- (approximately equal to 15% for the IC of IgG with Ka = 5 x 10(8) M(-1) and approximately equal to 7% for the IC of IgG with Ka = 2 x 10(7) M(-1)). This effect was dependent on antibody affinity and concentration; 3) there was a direct relationship between the overall level of complement activation, antibody affinity and superoxide production by neutrophils. Thus, we conclude that antibody affinity influences immune complex lattice formation, modulating its three-dimensional structure and the disposition of Fc fragments interfering with the antibody's biological properties. These results can help understand the precise role of antibody functional affinity in antigen-antibody complex diseases and define the immunochemical characteristics of pathogenic complexes.


Subject(s)
Antigen-Antibody Complex/immunology , Complement System Proteins/immunology , Immunoglobulin G/immunology , Neutrophils/immunology , Superoxides/analysis , Animals , Antibody Affinity , Antigen-Antibody Complex/biosynthesis , Antigen-Antibody Complex/chemistry , Complement Activation , Complement Fixation Tests , Complement System Proteins/biosynthesis , Complement System Proteins/chemistry , Immune Sera , Immunoglobulin G/biosynthesis , Immunoglobulin G/isolation & purification , Ovalbumin/immunology , Rabbits , Spectrophotometry , Superoxides/immunology
13.
Int Immunopharmacol ; 3(10-11): 1419-27, 2003 Oct.
Article in English | MEDLINE | ID: mdl-12946438

ABSTRACT

Propylthiouracil (PTU) was employed in a fixed quantity to evaluate the effect of the period of treatment with this drug on the antibody response to sheep red blood cells in Wistar rats. Animals were treated for 8, 16, 30 and 90 days by intragastric route with 5 mg/day, and immunized 24 h following the end of treatment; other groups were treated for 21 days, and immunized on the 17th day of treatment. Animals were sacrificed 5 or 6 days following immunization; the primary response was evaluated by the number of plaque-forming spleen cells and in some cases also by enzyme-linked immunosorbent assay (ELISA). Secondary response of PTU-treated rats, immunized and boostered after 15 days, was evaluated by ELISA 3 days following the booster. RIA performed the measurement of T3 in animals treated for 16 days, immunized, and sacrificed after 1, 2, 3, 4 and 5 days following immunization. Results showed that treatment for 8 and 16 days increased production of antibodies, and for 30 and 90 days decreased this response. Thus, according to the period of treatment, the same dose of PTU stimulates or suppresses the antibody response. This biphasic effect of a single dose of PTU was independent of alterations of serum levels of T3 during the buildup of the immune response. These results contributes towards the understanding of the literature controversy regarding the effects of this drug on the immune response, and could be of interest for studies involving autoimmune processes in thyroid.


Subject(s)
Antibody Formation/drug effects , Antithyroid Agents/pharmacology , Propylthiouracil/pharmacology , Administration, Oral , Animals , Antithyroid Agents/administration & dosage , Enzyme-Linked Immunosorbent Assay , Hemolytic Plaque Technique , Immunization , Male , Propylthiouracil/administration & dosage , Rats , Rats, Wistar , Spleen/immunology , Time Factors , Triiodothyronine/blood
14.
Lupus ; 11(4): 240-8, 2002.
Article in English | MEDLINE | ID: mdl-12043888

ABSTRACT

We have investigated the individual role of FcgammaR and CR, as well as their cooperation, in mediating the oxidative burst and degranulation of neutrophils of Brazilian systemic lupus erythematosus (SLE) patients. Neutrophils were stimulated with the immune complexes (IC)-IgG or -F(ab')2, opsonized or not with normal or SLE human serum. The oxidative burst was decreased in neutrophils of active SLE patients compared to healthy controls when this response was mediated by FcgammaR and/or CR, while the degranulation was unaffected. The SLE hypocomplementemia did not affect the oxidative burst mediated only by CR. FcgammaRII and CR1 expression on neutrophils of active SLE patients was reduced, while the expression of FcgammaRIII and CR3 was unaffected. These results suggest that the different FcgammaR and CR may be involved or cooperate in different ways in the mediation of the oxidative burst and the degranulation. Moreover, the decreased oxidative burst of neutrophils of active SLE patients may not depend only on SLE hypocomplementemia for IC opsonization. These observations are directed at the understanding of how each of these immune system components (FcgammaR, CR and complement) influences the precise biological neutrophil responses both in physiological and pathological conditions. Since the Brazilian population comprises many races, these results are important because they are directed at a specific population of SLE patients.


Subject(s)
Cell Degranulation , Lupus Erythematosus, Systemic/immunology , Lupus Erythematosus, Systemic/pathology , Neutrophils/immunology , Neutrophils/metabolism , Receptors, Complement/immunology , Receptors, IgG/immunology , Respiratory Burst , Brazil , Female , Gene Expression , Hemolysis , Humans , Immunoglobulin G/immunology , Luminescent Measurements , Male , Muramidase/metabolism , Neutrophils/cytology , Receptors, Complement/genetics , Receptors, IgG/genetics
15.
Braz. j. vet. res. anim. sci ; 32(3): 155-59, 1995. ilus, tab
Article in English | LILACS | ID: lil-240207

ABSTRACT

Neste trabalho foi analisado o efeito do grau de sensbilizaçäo de hemácias de carneiro por anticorpo, na resistência à lise pelo complemento do soro equino e de carneiro. Os resultados mostraram que, à medida que houve um aumento do nível de sensibilizaçäo, ocorreu também um aumento da atividade do complemento homólogo, levando a 100 por cento de lise; o mesmo foi observado para o complemento do soro equino, geralmente considerado ineficiente na lise destas células. A restriçäo à lise pode, assim, ser sobrepujada por este tratamento. Estes dados podem ser de interesse para a compreensäo dos mecanismos envolvidos na modulaçäo do fenômeno de restriçäo, na saúde e em doenças envolvendo o sistema complemento em animais domésticos e no homem, bem como em diagnóstico laboratorial, onde säo utilizados ensaios hemolíticos para medida de atividade do complemento e pesquisa de anticorpos em amostras de soro


Subject(s)
Animals , Antibodies , Erythrocytes , Goats/blood , Hemolysis , Horses/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...